603882 金域醫學
按盤價 
32.140 -0.350 (-1.077%) | 2025/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 2,996,929 | -22.78% | 7,189,545 | 8,539,628 | 15,476,075 | 11,943,224 | |
| 減：營業總成本 | 2,850,901 | -18.69% | 6,748,751 | 7,635,231 | 11,942,260 | 9,158,116 | |
| 其中:營業成本 | 1,979,983 | -21.80% | 4,806,526 | 5,424,536 | 8,801,575 | 6,295,018 | |
| 財務費用 | (2,728) | -2,137.73% | (2,774) | (1,054) | (12,568) | 10,088 | |
| 資產減值損失 | 125 | 116.03% | (72,623) | 519 | 232 | (519) | |
| 公允價值變動收益 | -- | -- | (30,799) | -- | -- | -- | |
| 投資收益 | 2,008 | -210.27% | (37,083) | 262,967 | (10,800) | (7,295) | |
| 其中：對聯營企業和合營企業的投資收益 | 283 | -112.88% | (15,924) | (9,815) | (13,208) | (8,848) | |
| 營業利潤 | (106,098) | -203.91% | (273,244) | 759,762 | 3,347,234 | 2,776,768 | |
| 利潤總額 | (109,608) | -213.14% | (438,647) | 740,289 | 3,320,730 | 2,747,557 | |
| 減：所得稅費用 | (12,740) | -193.57% | (23,943) | 103,380 | 475,721 | 384,046 | |
| 淨利潤 | (96,868) | -216.34% | (414,704) | 636,909 | 2,845,009 | 2,363,512 | |
| 減：非控股權益 | (12,061) | 88.80% | (33,463) | (6,474) | 90,222 | 143,871 | |
| 股東淨利潤 | (84,807) | -194.60% | (381,241) | 643,382 | 2,754,787 | 2,219,640 | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.180 | -194.74% | -0.820 | 1.380 | 5.910 | 4.800 | |
| 每股派息 (元) * | -- | -- | 0.880 | 0.880 | 1.780 | 1.280 | |
| 每股淨資產 (元) * | 14.732 | -11.95% | 15.813 | 17.840 | 18.477 | 13.540 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 28/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
